chr10-116675233-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_025015.3(HSPA12A):c.1576G>A(p.Ala526Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000075 in 1,613,686 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_025015.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HSPA12A | NM_025015.3 | c.1576G>A | p.Ala526Thr | missense_variant | 12/12 | ENST00000369209.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HSPA12A | ENST00000369209.8 | c.1576G>A | p.Ala526Thr | missense_variant | 12/12 | 1 | NM_025015.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000125 AC: 31AN: 248730Hom.: 0 AF XY: 0.000126 AC XY: 17AN XY: 135112
GnomAD4 exome AF: 0.0000547 AC: 80AN: 1461392Hom.: 0 Cov.: 31 AF XY: 0.0000578 AC XY: 42AN XY: 727020
GnomAD4 genome AF: 0.000269 AC: 41AN: 152294Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2022 | The c.1576G>A (p.A526T) alteration is located in exon 12 (coding exon 12) of the HSPA12A gene. This alteration results from a G to A substitution at nucleotide position 1576, causing the alanine (A) at amino acid position 526 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at